10x Genomics Market Sentiment

10x Genomics Inc

TXGNASDAQ

Trade with Public

$93.50

4.745.34%

Ult. Agg.: Oct 5, 7:39 AM

$94.90

6.146.92%

Panoramica Notizie Previsioni utili Eventi Obiettivi di prezzo Dati finanziariSentimentAzionariato Confronta Opzioni Rapporto azionario

10x Genomics Market Sentiment - Benzinga

10x Genomics Market Sentiment

Market sentiment signals for 10x Genomics (TXG): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus— Neutral

Short Interest▼ 18.8% short float

Options Flow— N/A

Insider Activity▼ Net Seller (30d)

Analyst Consensus

Neutral

22 analysts

Options Flow (P/C)

—

Avg Consensus PT

$46

-51.4%

Highest Price Target

$110

+15.9%

Argus Research

Lowest Price Target

-93.2%

Goldman Sachs

Short Interest

18.8%

Rising — Bearish

Insider Activity (30d)

Net Seller

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Sep 29, 2026	Leerink Partners	Mike Kratky—	-5.2%	$40 → $90	Maintained	Market Perform
Sep 28, 2026	Piper Sandler	David Westenberg—	-15.7%	$47 → $80	Maintained	Neutral
Sep 28, 2026	Argus Research	John Eade—	+15.9%	$110	Initiate	Buy
Sep 9, 2026	UBS	Dan Leonard—	-28.3%	$20 → $68	Maintained	Neutral
Sep 1, 2026	RBC Capital	Dan Leonard—	-26.2%	$70	Initiate	Sector Perform
Aug 12, 2026	Stephens & Co.	Mason Carrico—	-31.5%	$50 → $65	Maintained	Overweight
Aug 10, 2026	Piper Sandler	David Westenberg—	-50.5%	$42 → $47	Maintained	Neutral
Aug 10, 2026	Canaccord Genuity	Kyle Mikson—	-36.8%	$50 → $60	Maintained	Buy
Aug 7, 2026	Citigroup	Brendan Digan—	-47.3%	$45 → $50	Maintained	Neutral
Aug 7, 2026	Morgan Stanley	Tejas Savant—	-57.9%	$37 → $40	Maintained	Equal-Weight
Jul 17, 2026	Leerink Partners	Mike Kratky—	-57.9%	$23 → $40	Maintained	Market Perform
Jul 14, 2026	Canaccord Genuity	Kyle Mikson—	-47.3%	$32 → $50	Maintained	Buy
Jul 9, 2026	Morgan Stanley	Tejas Savant—	-61.0%	$22 → $37	Maintained	Equal-Weight
Jul 8, 2026	Citigroup	Patrick Donnelly—	-52.6%	$24 → $45	Maintained	Neutral
Jul 1, 2026	Piper Sandler	David Westenberg—	-55.7%	$20 → $42	Maintained	Neutral
Jun 24, 2026	Barclays	Luke Sergott—	-57.9%	$30 → $40	Maintained	Overweight
May 12, 2026	Morgan Stanley	Tejas Savant—	-76.8%	$20 → $22	Maintained	Equal-Weight
May 12, 2026	JP Morgan	Casey Woodring—	-78.9%	$17 → $20	Maintained	Neutral
Apr 20, 2026	Canaccord Genuity	Kyle Mikson—	-66.3%	$22 → $32	Maintained	Buy
Apr 20, 2026	B of A Securities	Derik De Bruin—	-68.4%	$21 → $30	Maintained	Neutral
Apr 14, 2026	Barclays	Luke Sergott—	-68.4%	$22 → $30	Maintained	Overweight
Apr 7, 2026	Citigroup	Patrick Donnelly—	-74.7%	$18 → $24	Maintained	Neutral
Mar 31, 2026	William Blair	Matt Larew—	—	—	Upgrade	Market Perform→Outperform
Mar 2, 2026	Stifel	Daniel Arias—	-73.7%	$20 → $25	Maintained	Buy
Feb 20, 2026	UBS	Dan Leonard—	-78.9%	$14 → $20	Maintained	Neutral